2019
DOI: 10.1016/j.ydbio.2019.07.012
|View full text |Cite
|
Sign up to set email alerts
|

Lineage tracing of col10a1 cells identifies distinct progenitor populations for osteoblasts and joint cells in the regenerating fin of medaka (Oryzias latipes)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(20 citation statements)
references
References 46 publications
1
19
0
Order By: Relevance
“…We therefore tested whether osteoblasts are the sole source for Cxcl9l required for osteoclast recruitment. As cxcl9l was up-regulated in col10a1 osteoblast progenitors as well as in premature osx -positive osteoblasts ( SI Appendix , Tables S1 and S3 ), we made use of an established osx :mCherry-NTRo line to genetically ablate premature osteoblasts using a Nitroreductase (NTRo) approach as described earlier ( 28 , 29 ) and quantified the formation of ctsk osteoclasts after Rankl induction. Metronidazole (Mtz) treatment of osx :mCherry-NTRo/ rankl :HSE: cfp / ctsk :GFP transgenic medaka at 9 dpf for 24 h resulted in an almost complete ablation of osteoblasts from the vertebral column under both Rankl− and Rankl+ conditions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…We therefore tested whether osteoblasts are the sole source for Cxcl9l required for osteoclast recruitment. As cxcl9l was up-regulated in col10a1 osteoblast progenitors as well as in premature osx -positive osteoblasts ( SI Appendix , Tables S1 and S3 ), we made use of an established osx :mCherry-NTRo line to genetically ablate premature osteoblasts using a Nitroreductase (NTRo) approach as described earlier ( 28 , 29 ) and quantified the formation of ctsk osteoclasts after Rankl induction. Metronidazole (Mtz) treatment of osx :mCherry-NTRo/ rankl :HSE: cfp / ctsk :GFP transgenic medaka at 9 dpf for 24 h resulted in an almost complete ablation of osteoblasts from the vertebral column under both Rankl− and Rankl+ conditions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To generate osx:cxcl9l-p2a-mCherry and osx:cxcl9l-p2a-EGFP plasmids for Cxcl9l overexpression, the medaka osx promoter (16) was cloned upstream of the cxcl9l coding sequence amplified from medaka cDNA using primers cxcl9lF and cxcl9lR (SI Appendix, Table S5). For osx:cxcl9l-p2a-mCherry, the cxcl9l stop codon was replaced with p2a-mCherry amplified from plasmid col10a1:creERT2-p2a-mCherry (29). For osx:cxcl9l-p2a-EGFP, mCherry from osx:cxcl9l-p2a-mCherry was replaced with EGFP.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In zebrafish, which are capable of complex organ regeneration, intramembranous bones of the fins and skull regenerate rapidly even after profound loss. Fin regeneration, a widely studied phenomenon of adult tissue re-growth upon fin resection (amputation) is driven by a tissue referred to as the blastema, which arises from mature cells undergoing dedifferentiation and a pool of reserved progenitor cells (13). The fin regenerate, being composed of different tissues (epidermis, bone, mesenchyme, blood vessels, nerves) is a structure of modest complexity which, together with the fact that it is easy to access and monitor, makes it a valuable system to study bone formation, wound healing, and cell metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…NTR/Mtz system has been used to tease out the functions of specific cell types in a complex process of organ regeneration in zebrafish, including the heart (Curado et al, 2007;Wang et al, 2013;Zhang et al, 2013), fin (Petrie et al, 2014), pancreatic β-cells (Pisharath et al, 2007), bone (Willems et al, 2012) and RPE regeneration (Hanovice et al, 2019). This system is also applicable to medaka, demonstrated by accessing regeneration capacity using NTR/Mtz mediated genetic ablation of the pancreatic β-cell population (Otsuka and Takeda, 2017), osteoblasts (Willems et al, 2012), and bone progenitor cells (Dasyani et al, 2019) in fin regeneration.…”
Section: Injury Modelsmentioning
confidence: 99%